Kura Oncology Shares Are Trading Lower. The Company Announced It Entered Into a Global Strategic Collaboration With Kyowa Kirin to Develop and Commercialize Ziftomenib.
Kura Oncology Shares Are Trading Lower. The Company Announced It Entered Into a Global Strategic Collaboration With Kyowa Kirin to Develop and Commercialize Ziftomenib.
kura oncology的股票正在下跌。該公司宣佈已與驚和藥品（Kyowa Kirin）達成全球貨幣戰略合作，以開發和商業化Ziftomenib。
Kura Oncology Shares Are Trading Lower. The Company Announced It Entered Into a Global Strategic Collaboration With Kyowa Kirin to Develop and Commercialize Ziftomenib.
kura oncology的股票在下跌。該公司宣佈與昌榮製藥達成全球貨幣戰略合作，共同開發和商業化Ziftomenib。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間